These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1665830)

  • 1. Angiotensin-II activation of cAMP and corticosterone production in bovine adrenocortical cells: effects of nonpeptide angiotensin-II antagonists.
    Rainey WE; Byrd EW; Sinnokrot RA; Carr BR
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):33-41. PubMed ID: 1665830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
    Balla T; Baukal AJ; Eng S; Catt KJ
    Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II stimulates growth and steroidogenesis in zona fasciculata/reticularis cells from bovine adrenal cortex via the AT1 receptor subtype.
    Clyne CD; Nicol MR; MacDonald S; Williams BC; Walker SW
    Endocrinology; 1993 May; 132(5):2206-12. PubMed ID: 8386614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
    García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
    J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-II acts via the type 1 receptor to inhibit 17 alpha-hydroxylase cytochrome P450 expression in ovine adrenocortical cells.
    Bird IM; Magness RR; Mason JI; Rainey WE
    Endocrinology; 1992 Jun; 130(6):3113-21. PubMed ID: 1317775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
    Regitz-Zagrosek V; Auch-Schwelk W; Hess B; Klein U; Duske E; Steffen C; Hildebrandt AG; Fleck E
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):66-72. PubMed ID: 7564368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor.
    Lara LS; Bica RB; Sena SL; Correa JS; Marques-Fernandes MF; Lopes AG; Caruso-Neves C
    Regul Pept; 2002 Jan; 103(1):17-22. PubMed ID: 11738244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
    Gironacci MM; Adler-Graschinsky E; Peña C; Enero MA
    Hypertension; 1994 Oct; 24(4):457-60. PubMed ID: 8088911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin II and nonpeptide receptor antagonists on transduction pathways in rat proximal tubule.
    Poggioli J; Lazar G; Houillier P; Gardin JP; Achard JM; Paillard M
    Am J Physiol; 1992 Oct; 263(4 Pt 1):C750-8. PubMed ID: 1329542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin II potentiates the effect of ACTH on the production of cyclic AMP by bovine adrenal cells in primary culture].
    Morera AM; Andoka G; Chauvin MA
    C R Acad Sci III; 1984; 298(17):507-12. PubMed ID: 6331610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of angiotensin-II and corticotropin on bovine adrenocortical cell steroidogenic responsiveness.
    Ouali R; Langlois D; Saez JM; Begeot M
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):43-52. PubMed ID: 1665831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the stimulation of rat adrenal capsular cells: four types of response.
    Tait JF; Tait SA; Bell JB; Hyatt PJ; Williams BC
    J Endocrinol; 1980 Oct; 87(1):11-27. PubMed ID: 6253588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
    Symons JD; Stebbins CL
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.